Observation, Not Radiotherapy, After Radical Prostatectomy

The investigators observed no benefit to adjuvant radiotherapy after radical prostatectomy in patients with prostate cancer in the phase 3 RADICALS-RT trial.

Related Keywords

Salford ,United Kingdom ,Manchester ,Australia ,Roche Genentech ,Noel Clarke ,Shahneed Sandhu ,Merck Serono ,Bristol Myers Squibb ,Novartis ,Amgen ,Pfizer ,Astrazeneca ,Peter Maccallum Cancer Centre ,European Society For Medical Oncology ,European Society ,Medical Oncology ,Christie Hospital ,Salford Royal Hospital ,Advanced Accelerator Application ,Merck Sharp ,Prostate Carcinoma ,Alignant Prostate Neoplasm ,Prostate Cancer ,Ancer Prostate ,Radiation Oncology ,Radical Prostatectomy ,Biologic Therapy ,Prostatectomy ,Toxicology ,Metastasis ,Cancer ,Alignant Neoplasia ,Arcinoma ,Prostatic ,Prostate Specific Antigen Psa ,Prostate Specific Antigen ,Sa ,Distant Metastasis ,Istant Metastases ,Antigens ,Hospitals ,Fecal Incontinence ,